Literature DB >> 17962591

Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid.

Shawn N Whitehead1, Guanliang Cheng, Vladimir C Hachinski, David F Cechetto.   

Abstract

BACKGROUND AND
PURPOSE: In the elderly, cerebral ischemia (CI) occurs in the presence of high levels of amyloid. Neuroinflammation plays a critical role in the pathophysiology of Alzheimer's disease and CI. This study examined infarct size, neuroinflammation, and cognitive deficits over time in rat models of Alzheimer's disease and CI.
METHODS: beta-amyloid toxicity was modeled using bilateral intracerebroventricular injections of beta-amyloid 25 to 35 peptides. CI was modeled using unilateral injections of the potent vasoconstrictor, endothelin-1, into the striatum.
RESULTS: Infarct volumes were higher in the presence of amyloid and compared with the CI model alone. In the CI model alone, the infarct volume was significantly smaller 28 days after surgery compared with 7 days after surgery. However, when Alzheimer's disease and CI models were combined, the infarct volume was significantly larger 28 days after surgery compared with 7 days after surgery. The neuroinflammation in the region of the infarct was also significantly increased. The Barnes circular platform test showed time-dependent increases in memory and learning deficits in the beta-amyloid-treated rats that were even greater when beta-amyloid treatment was combined with CI.
CONCLUSIONS: CI in the presence of high levels of amyloid results in progressive increases in infarct size, neuroinflammation, and cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962591     DOI: 10.1161/STROKEAHA.107.492660

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

Review 1.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

2.  Trajectory of Cognitive Decline After Incident Stroke.

Authors:  Deborah A Levine; Andrzej T Galecki; Kenneth M Langa; Frederick W Unverzagt; Mohammed U Kabeto; Bruno Giordani; Virginia G Wadley
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

Review 3.  Preventing dementia by preventing stroke: The Berlin Manifesto.

Authors:  Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

4.  APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.

Authors:  Sarah T Pendlebury; Debbie Poole; Annette Burgess; Julia Duerden; Peter M Rothwell
Journal:  Stroke       Date:  2020-02-18       Impact factor: 7.914

5.  Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion.

Authors:  Victor K L Hung; Patrick K K Yeung; Angela K W Lai; Maggie C Y Ho; Amy C Y Lo; Kevin C Chan; Ed X K Wu; Stephen S M Chung; Chi W Cheung; Sookja K Chung
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

Review 6.  PET imaging in ischemic cerebrovascular disease: current status and future directions.

Authors:  Wolf-Dieter Heiss
Journal:  Neurosci Bull       Date:  2014-08-19       Impact factor: 5.203

7.  Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Authors:  David E Vance; Graham J McDougall; Natalie Wilson; Marcus Otavio Debiasi; Shameka L Cody
Journal:  Top Geriatr Rehabil       Date:  2014-01

Review 8.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 9.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

Review 10.  Antihypertensive treatment can prevent stroke and cognitive decline.

Authors:  Peter Sörös; Shawn Whitehead; J David Spence; Vladimir Hachinski
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.